▶ 調査レポート

小児用医療製品・サービスの世界市場分析・規模・シェア・成長・動向・予測:薬剤分類別(抗生物質、鎮痛薬、抗喘息薬、抗うつ薬、抗うつ薬、下痢止、抗真菌薬、抗ヒスタミン薬、降圧剤、抗代謝薬、抗悪性腫瘍性抗生物質、抗精神病薬)、疾患/障害別(アレルギー・呼吸器、癌、心血管、中枢神経系胃腸薬、ホルモン失調、感染症)、サービス種類別(小児精神科、消化器、小児がん、小児糖尿病、小児心臓病)

• 英文タイトル:Pediatric Health Care Products and Services Market (Drug Class - Antibiotics, Analgesics, Anti-asthmatics, Antidepressants, Antidiarrheal, Antifungal, Anti-histamines, Antihypertensives, Anti-metabolites, Anti-neoplastic Antibiotics, Antipsychotics; Disease/Disorder - Allergy and Respiratory, Cancer, Cardiovascular, Central Nervous System, Gastrointestinal, Hormonal Imbalance, Infections; Service Type - Child Psychiatry Services, Gastrointestinal Services, Pediatric Cancer Services, Pediatric Diabetes Services, Pediatric Heart Services) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Transparency Market Researchが調査・発行した産業分析レポートです。小児用医療製品・サービスの世界市場分析・規模・シェア・成長・動向・予測:薬剤分類別(抗生物質、鎮痛薬、抗喘息薬、抗うつ薬、抗うつ薬、下痢止、抗真菌薬、抗ヒスタミン薬、降圧剤、抗代謝薬、抗悪性腫瘍性抗生物質、抗精神病薬)、疾患/障害別(アレルギー・呼吸器、癌、心血管、中枢神経系胃腸薬、ホルモン失調、感染症)、サービス種類別(小児精神科、消化器、小児がん、小児糖尿病、小児心臓病) / Pediatric Health Care Products and Services Market (Drug Class - Antibiotics, Analgesics, Anti-asthmatics, Antidepressants, Antidiarrheal, Antifungal, Anti-histamines, Antihypertensives, Anti-metabolites, Anti-neoplastic Antibiotics, Antipsychotics; Disease/Disorder - Allergy and Respiratory, Cancer, Cardiovascular, Central Nervous System, Gastrointestinal, Hormonal Imbalance, Infections; Service Type - Child Psychiatry Services, Gastrointestinal Services, Pediatric Cancer Services, Pediatric Diabetes Services, Pediatric Heart Services) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 / TPM-BG111資料のイメージです。• レポートコード:TPM-BG111
• 出版社/出版日:Transparency Market Research / 2018年6月
• レポート形態:英文、PDF、271ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥614,270 (USD5,795)▷ お問い合わせ
  Multi User¥932,270 (USD8,795)▷ お問い合わせ
  Global Site License¥1,250,270 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、小児用医療製品・サービスの世界市場について調べ、小児用医療製品・サービスの世界規模、市場動向、市場環境、薬剤分類別(抗生物質、鎮痛薬、抗喘息薬、抗うつ薬、抗うつ薬、下痢止、抗真菌薬、抗ヒスタミン薬、降圧剤、抗代謝薬、抗悪性腫瘍性抗生物質、抗精神病薬)分析、疾患/障害別(アレルギー・呼吸器、癌、心血管、中枢神経系胃腸薬、ホルモン失調、感染症)分析、サービス種類別(小児精神科、消化器、小児がん、小児糖尿病、小児心臓病)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・小児用医療製品・サービスの世界市場動向
・小児用医療製品・サービスの世界市場環境
・小児用医療製品・サービスの世界市場規模
・小児用医療製品・サービスの世界市場規模:薬剤分類別(抗生物質、鎮痛薬、抗喘息薬、抗うつ薬、抗うつ薬、下痢止、抗真菌薬、抗ヒスタミン薬、降圧剤、抗代謝薬、抗悪性腫瘍性抗生物質、抗精神病薬)
・小児用医療製品・サービスの世界市場規模:疾患/障害別(アレルギー・呼吸器、癌、心血管、中枢神経系胃腸薬、ホルモン失調、感染症)
・小児用医療製品・サービスの世界市場規模:サービス種類別(小児精神科、消化器、小児がん、小児糖尿病、小児心臓病)
・小児用医療製品・サービスの世界市場:地域別市場規模・分析
・小児用医療製品・サービスの北米市場規模・予測
・小児用医療製品・サービスのアメリカ市場規模・予測
・小児用医療製品・サービスの中南米市場規模・予測
・小児用医療製品・サービスのヨーロッパ市場規模・予測
・小児用医療製品・サービスのアジア市場規模・予測
・小児用医療製品・サービスの日本市場規模・予測
・小児用医療製品・サービスの中国市場規模・予測
・小児用医療製品・サービスのインド市場規模・予測
・小児用医療製品・サービスの中東市場規模・予測
・小児用医療製品・サービスのアフリカ市場規模・予測
・競争状況・関連企業情報

Global Pediatric Health Care Products and Services Market: Overview

This report on the pediatric health care products and services market analyzes the current and future scenario of the global market. Expansion of the pediatric health care products and services market is attributed to unhealthy lifestyle habits; rise in obese pediatric population; increase in funding for pediatric research, which contributes to new product launches; growth in awareness regarding pediatric care; economic growth in emerging markets; and technical advancement in the sector. Moreover, launch of new drugs by pharmaceutical companies for pediatric patients and increase in focus by global research bodies on the development of new and improved drugs for children are expected to drive the growth of the market during the forecast period.

The pediatric health care products and services market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on drug class, disease/ disorder, services type, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis, by key players, thus presenting a thorough analysis of the overall competitive scenario in the pediatric health care products and services market.

Global Pediatric Health Care Products and Services Market: Key Segments

In terms of drug class, the market is segmented into antibiotics, analgesics, anti-asthmatics, antidepressants, antidiarrheal, antifungal, anti-histamines, antihypertensives, anti-metabolites, anti-neoplastic antibiotics, antipsychotics, and others. Based on disease/ disorder, the market is further divided into allergy and respiratory, cancer, cardiovascular, central nervous system, gastrointestinal, hormonal imbalance, infections, and others. In terms of services type, the global pediatric health care products and services market is categorized into child psychiatry services, gastrointestinal services, pediatric cancer services, pediatric diabetes services, pediatric heart services, and others. The market size and forecast for each of these segments have been provided in terms of US$ Mn for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Pediatric Health Care Products and Services Market: Regional Outlook

The global pediatric health care products and services market is categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (GCC Countries, South Africa, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global pediatric health care products and services market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players in the market include Pfizer Inc., GlaxoSmithKline plc. Merck & Co., Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Gilead Sciences, Inc., Sanofi S.A., Pediapharm, Inc., Novartis AG, Eisai Co., Ltd. and Mylan N.V.

The global pediatric health care products and services market is segmented as given below:

Global Pediatric Health Care Products and Services Market, by Drug Class
Antibiotics
Analgesics
Anti-asthmatics
Antidepressants
Antidiarrheal
Antifungal
Anti-histamines
Antihypertensives
Anti-metabolites
Anti-neoplastic Antibiotics
Antipsychotics
Others
Global Pediatric Health Care Products and Services Market, by Disease/Disorder
Allergy and Respiratory
Cancer
Cardiovascular
Central Nervous System
Gastrointestinal
Hormonal Imbalance
Infections
Others
Global Pediatric Health Care Products and Services Market, by Services Type
Child Psychiatry Services
Gastrointestinal Services
Pediatric Cancer Services
Pediatric Diabetes Services
Pediatric Heart Services
Others
Global Pediatric Health Care Products and Services Market, by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of MEA

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pediatric Health Care Products and Services Market

4. Market Overview
4.1. Introduction
4.1.1. Disorder/Disease Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, 2016–2026
4.4.1. Market Revenue Projections, by Product Type (US$ Mn)
4.4.2. Market Revenue Projections, by Services Type (US$ Mn)

5. Market Overview
5.1. Clinical Trial Analysis
5.2. Disease Incidence and Prevalence
5.3. Regulatory Framework

6. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Disorder/Disease
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast by Disorder/Disease, 2016–2026
6.3.1. Allergy and Respiratory
6.3.2. Cancer
6.3.3. Cardiovascular
6.3.4. Central Nervous System
6.3.5. Gastrointestinal
6.3.6. Hormonal Imbalance
6.3.7. Infections
6.3.8. Others
6.4. Market Attractiveness by Disorder/Disease

7. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Drug Class
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast by Drug Class, 2016–2026
7.3.1. Antibiotics
7.3.2. Analgesics
7.3.3. Anti-asthmatics
7.3.4. Antidepressants
7.3.5. Antidiarrheal
7.3.6. Antifungal
7.3.7. Anti-histamines
7.3.8. Antihypertensives
7.3.9. Anti-metabolites
7.3.10. Anti-neoplastic Antibiotics
7.3.11. Antipsychotics
7.3.12. Others

8. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Services
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast by Services, 2016–2026
8.3.1. Child Psychiatry Services
8.3.2. Gastrointestinal Services
8.3.3. Pediatric Cancer Services
8.3.4. Pediatric Diabetes Services
8.3.5. Pediatric Heart Services
8.3.6. Others

9. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness by Country/Region

10. North America Pediatric Health Care Products and Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast by Disorder/Disease, 2016–2026
10.2.1. Allergy and Respiratory
10.2.2. Cancer
10.2.3. Cardiovascular
10.2.4. Central Nervous System
10.2.5. Gastrointestinal
10.2.6. Hormonal Imbalance
10.2.7. Infections
10.2.8. Others
10.3. Market Value Forecast by Drug Class, 2016–2026
10.3.1. Antibiotics
10.3.2. Analgesics
10.3.3. Anti-asthmatics
10.3.4. Antidepressants
10.3.5. Antidiarrheal
10.3.6. Antifungal
10.3.7. Anti-histamines
10.3.8. Antihypertensives
10.3.9. Anti-metabolites
10.3.10. Anti-neoplastic Antibiotics
10.3.11. Antipsychotics
10.3.12. Others
10.4. Market Value Forecast by Services, 2016–2026
10.4.1. Child Psychiatry Services
10.4.2. Gastrointestinal Services
10.4.3. Pediatric Cancer Services
10.4.4. Pediatric Diabetes Services
10.4.5. Pediatric Heart Services
10.4.6. Others
10.5. Market Value Forecast by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Disorder/Disease
10.6.2. By Drug Class
10.6.3. By Services
10.6.4. By Country

11. Europe Pediatric Health Care Products and Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast by Disorder/Disease, 2016–2026
11.2.1. Allergy and Respiratory
11.2.2. Cancer
11.2.3. Cardiovascular
11.2.4. Central Nervous System
11.2.5. Gastrointestinal
11.2.6. Hormonal Imbalance
11.2.7. Infections
11.2.8. Others
11.3. Market Value Forecast by Drug Class, 2016–2026
11.3.1. Antibiotics
11.3.2. Analgesics
11.3.3. Anti-asthmatics
11.3.4. Antidepressants
11.3.5. Antidiarrheal
11.3.6. Antifungal
11.3.7. Anti-histamines
11.3.8. Antihypertensives
11.3.9. Anti-metabolites
11.3.10. Anti-neoplastic Antibiotics
11.3.11. Antipsychotics
11.3.12. Others
11.4. Market Value Forecast by Services, 2016–2026
11.4.1. Child Psychiatry Services
11.4.2. Gastrointestinal Services
11.4.3. Pediatric Cancer Services
11.4.4. Pediatric Diabetes Services
11.4.5. Pediatric Heart Services
11.4.6. Others
11.5. Market Value Forecast by Country, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Disorder/Disease
11.6.2. By Drug Class
11.6.3. By Services
11.6.4. By Country

12. Asia Pacific Pediatric Health Care Products and Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast by Disorder/Disease, 2016–2026
12.2.1. Allergy and Respiratory
12.2.2. Cancer
12.2.3. Cardiovascular
12.2.4. Central Nervous System
12.2.5. Gastrointestinal
12.2.6. Hormonal Imbalance
12.2.7. Infections
12.2.8. Others
12.3. Market Value Forecast by Drug Class, 2016–2026
12.3.1. Antibiotics
12.3.2. Analgesics
12.3.3. Anti-asthmatics
12.3.4. Antidepressants
12.3.5. Antidiarrheal
12.3.6. Antifungal
12.3.7. Anti-histamines
12.3.8. Antihypertensives
12.3.9. Anti-metabolites
12.3.10. Anti-neoplastic Antibiotics
12.3.11. Antipsychotics
12.3.12. Others
12.4. Market Value Forecast by Services, 2016–2026
12.4.1. Child Psychiatry Services
12.4.2. Gastrointestinal Services
12.4.3. Pediatric Cancer Services
12.4.4. Pediatric Diabetes Services
12.4.5. Pediatric Heart Services
12.4.6. Others
12.5. Market Value Forecast by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Disorder/Disease
12.6.2. By Drug Class
12.6.3. By Services
12.6.4. By Country

13. Latin America Pediatric Health Care Products and Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast by Disorder/Disease, 2016–2026
13.2.1. Allergy and Respiratory
13.2.2. Cancer
13.2.3. Cardiovascular
13.2.4. Central Nervous System
13.2.5. Gastrointestinal
13.2.6. Hormonal Imbalance
13.2.7. Infections
13.2.8. Others
13.3. Market Value Forecast by Drug Class, 2016–2026
13.3.1. Antibiotics
13.3.2. Analgesics
13.3.3. Anti-asthmatics
13.3.4. Antidepressants
13.3.5. Antidiarrheal
13.3.6. Antifungal
13.3.7. Anti-histamines
13.3.8. Antihypertensives
13.3.9. Anti-metabolites
13.3.10. Anti-neoplastic Antibiotics
13.3.11. Antipsychotics
13.3.12. Others
13.4. Market Value Forecast by Services, 2016–2026
13.4.1. Child Psychiatry Services
13.4.2. Gastrointestinal Services
13.4.3. Pediatric Cancer Services
13.4.4. Pediatric Diabetes Services
13.4.5. Pediatric Heart Services
13.4.6. Others
13.5. Market Value Forecast by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Disorder/Disease
13.6.2. By Drug Class
13.6.3. By Services
13.6.4. By Country

14. Middle East & Africa Pediatric Health Care Products and Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast by Disorder/Disease, 2016–2026
14.2.1. Allergy and Respiratory
14.2.2. Cancer
14.2.3. Cardiovascular
14.2.4. Central Nervous System
14.2.5. Gastrointestinal
14.2.6. Hormonal Imbalance
14.2.7. Infections
14.2.8. Others
14.3. Market Value Forecast by Drug Class, 2016–2026
14.3.1. Antibiotics
14.3.2. Analgesics
14.3.3. Anti-asthmatics
14.3.4. Antidepressants
14.3.5. Antidiarrheal
14.3.6. Antifungal
14.3.7. Anti-histamines
14.3.8. Antihypertensives
14.3.9. Anti-metabolites
14.3.10. Anti-neoplastic Antibiotics
14.3.11. Antipsychotics
14.3.12. Others
14.4. Market Value Forecast by Services, 2016–2026
14.4.1. Child Psychiatry Services
14.4.2. Gastrointestinal Services
14.4.3. Pediatric Cancer Services
14.4.4. Pediatric Diabetes Services
14.4.5. Pediatric Heart Services
14.4.6. Others
14.5. Market Value Forecast by Country, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Disorder/Disease
14.6.2. By Drug Class
14.6.3. By Services
14.6.4. By Country

15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Company Profiles
15.2.1. AstraZeneca plc
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Development
15.2.1.4. Strategy
15.2.2. Boehringer Ingelheim GmbH
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Development
15.2.2.4. Strategy
15.2.3. Eisai Co., Ltd.
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Development
15.2.3.4. Strategy
15.2.4. Gilead Sciences, Inc.
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Development
15.2.4.4. Strategy
15.2.5. GlaxoSmithKline plc
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Development
15.2.5.4. Strategy
15.2.6. Merck & Co., Inc.
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Development
15.2.6.4. Strategy
15.2.7. Mylan N.V.
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Development
15.2.7.4. Strategy
15.2.8. Novartis AG
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Development
15.2.8.4. Strategy
15.2.9. Pediapharm, Inc.
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Development
15.2.9.4. Strategy
15.2.10. Pfizer Inc.
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Development
15.2.10.4. Strategy
15.2.11. Sanofi S.A.
15.2.11.1. Overview (HQ, Employee Strength, Business Segments)
15.2.11.2. Financials
15.2.11.3. Recent Development
15.2.11.4. Strategy

List of Tables

Table 01: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 02: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 03: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026
Table 04: Global Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: Global Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 08: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 09: North America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 10: North America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service type, 2016–2026
Table 11: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 13: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 14: Europe Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 15: Europe Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Services Type, 2016–2026
Table 16: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 18: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 19: Asia Pacific Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Asia Pacific Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Services Type, 2016–2026
Table 21: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 23: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 24: Latin America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Latin America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026
Table 26: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 28: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 29: Middle East & Africa Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Middle East & Africa Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026